DDB as an agent against BEL-7402 human hepatocarcinoma
    1.
    发明授权
    DDB as an agent against BEL-7402 human hepatocarcinoma 失效
    DDB作为抗BEL-7402人肝癌的药物

    公开(公告)号:US5155111A

    公开(公告)日:1992-10-13

    申请号:US518271

    申请日:1990-05-07

    申请人: Geng-Tao Liu

    发明人: Geng-Tao Liu

    IPC分类号: A61K31/36 A61K31/52

    CPC分类号: A61K31/36 A61K31/52

    摘要: Dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate (DDB), a synthetic analogue of Schizandrin C, is a useful chemotherapeutic agent for the treatment of BEL-7402 human hepatocarcinoma when used in combination with 6-mercaptopurine.

    摘要翻译: 二甲基-4,4'-二甲氧基-5,6,5',6'-二亚甲基二氧基联苯-2,2'-二羧酸(DDB)是一种合成类似物,其是五味子素C,是一种有用的化学治疗剂,用于治疗BEL- 7402人肝癌与6-巯基嘌呤联合使用时。